摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-ethylphenyl)-2-(2-fluoro-4-pyridyl)ethanone | 365428-36-0

中文名称
——
中文别名
——
英文名称
1-(3-ethylphenyl)-2-(2-fluoro-4-pyridyl)ethanone
英文别名
1-(3-ethylphenyl)-2-(2-fluoropyridin-4-yl)ethanone
1-(3-ethylphenyl)-2-(2-fluoro-4-pyridyl)ethanone化学式
CAS
365428-36-0
化学式
C15H14FNO
mdl
——
分子量
243.281
InChiKey
CMTBRUURJRAIOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    30
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Substituted 1,3-thiazole compounds, their production and use
    申请人:——
    公开号:US20040053973A1
    公开(公告)日:2004-03-18
    (1) A 1,3-thiazole compound of which the 5-position is substituted with a 4-pyridyl group having a substituent including no aromatic group or (2) a 1,3-thiazole compound of which the 5-position is substituted with a pyridyl group having at the position adjacent to a nitrogen atom of the pyridyl group a substituent including no aromatic group has an excellent p38 MAP kinase inhibitory activity.
    (1) 一种1,3-噻唑化合物,其5位被取代为含有一个取代基的4-吡啶基团,该取代基不包括芳香基,或者(2) 一种1,3-噻唑化合物,其5位被取代为一个吡啶基团,该吡啶基团的氮原子邻近位置有一个取代基,该取代基不包括芳香基,具有出色的p38 MAP激酶抑制活性。
  • MEDICINAL COMPOSITIONS
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1402900A1
    公开(公告)日:2004-03-31
    The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.
    本发明涉及一种用于预防或治疗疼痛的药剂,一种用于抑制破骨细胞活化的药剂,以及一种包含p38 MAP激酶抑制剂和/或TNF-α产生抑制剂的破骨细胞形成抑制剂。
  • Medicinal compositions
    申请人:Ohkawa Shigenori
    公开号:US20050080113A1
    公开(公告)日:2005-04-14
    The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.
    本发明涉及一种用于预防或治疗疼痛的药剂,一种用于抑制成骨细胞活化的药剂,以及一种抑制成骨细胞形成的抑制剂,其中包含p38 MAP激酶抑制剂和/或TNF-α生产抑制剂。
  • [EN] SUBSTITUTED 1,3-THIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE<br/>[FR] COMPOSES DE 1,3-THIAZOLE SUBSTITUES, PRODUCTION ET UTILISATION DESDITS COMPOSES
    申请人:TAKEDA CHEMICAL INDUSTRIES LTD
    公开号:WO2001074811A2
    公开(公告)日:2001-10-11
    (1) A 1,3-thiazole compound of which the 5-position is substituted with a 4-pyridyl group having a substituent including no aromatic group or (2) a 1,3-thiazole compound of which the 5-position is substituted with a pyridyl group having at the position adjacent to a nitrogen atom of the pyridyl group a substituent including no aromatic group has an excellent p38 MAP kinase inhibitory activity.
    (1) 一种1,3-噻唑化合物,其中5位被一个带有不包括芳香族的取代基的4-吡啶基取代,或者(2)一种1,3-噻唑化合物,其中5位被一个在吡啶基的氮原子邻近位置带有不包括芳香族的取代基的吡啶基取代。这类化合物展现出优异的p38丝裂原活化蛋白激酶抑制活性。
  • SUBSTITUTED 1,3-THIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1268474A2
    公开(公告)日:2003-01-02
查看更多